Recent Annual Filings for AMED

Fiscal Year Assets Revenues Costs & Expenses Comprehensive Income Cash Flow - Operating Cash Flow - Financing Total Net Cash Flow
2024 $2,138,714,000 $2,348,324,000 $2,253,786,000 $38,162,000 $221,665,000 $-48,922,000 $164,379,000
2023 $2,060,170,000 $2,236,382,000 $2,079,988,000 $-10,936,000 $137,188,000 $-87,522,000 $84,730,000
2022 $1,976,245,000 $2,223,199,000 $2,042,427,000 $117,699,000 $133,283,000 $-30,433,000 $8,364,000
2021 $1,856,968,000 $2,214,112,000 $1,975,497,000 $210,166,000 $188,893,000 $55,126,000 $-37,588,000
2020 $1,567,198,000 $2,071,519,000 $1,886,623,000 $185,184,000 $288,952,000 $-14,977,000 $-13,133,000
2019 $1,262,745,000 $1,955,633,000 $1,778,161,000 $127,907,000 $202,000,000 $227,209,000 $76,261,000
2018 $717,118,000 $1,662,600,000 $1,507,430,000 $120,129,000 $223,483,000 $-267,424,000 $-66,134,000
2017 $813,482,000 $1,533,680,000 $1,455,200,000 $30,683,000 $105,731,000 $-5,538,000 $56,166,000